Synjardy XR 12.5 mg/1
empagliflozin, metformin hydrochloride · TABLET, EXTENDED RELEASE · Boehringer Ingelheim Pharmaceuticals, Inc.
Synjardy XR is a tablet, extended release containing empagliflozin, metformin hydrochloride at 12.5 mg/1, taken oral. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Synjardy XR
- Generic Name
- empagliflozin, metformin hydrochloride
- NDC Code (Product)
0597-0300- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Strength
- 12.5 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA208658
- Drug Class
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
- Marketing Start
- 12/10/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is Synjardy XR used for?
Synjardy XR contains empagliflozin, metformin hydrochloride. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is Synjardy XR a controlled substance?
Synjardy XR is not classified as a controlled substance by the DEA.
What is the generic name for Synjardy XR?
The generic name for Synjardy XR is empagliflozin, metformin hydrochloride. There are no other listed brand versions of empagliflozin, metformin hydrochloride.
What is the NDC code for Synjardy XR 12.5 mg/1?
The NDC (National Drug Code) for Synjardy XR 12.5 mg/1 is 0597-0300, listed by Boehringer Ingelheim Pharmaceuticals, Inc..
Other Synjardy XR Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)